Vertex Pharmaceuticals (VRTX) Change in Account Payables (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Change in Account Payables of -$66.7 million for Q2 2026, down 287.36% on a QoQ basis from $35.6 million in Q1 2026, and down 977.63% year-over-year from $7.6 million in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Change in Account Payables (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Change in Account Payables for 18 years, with the latest figure at -$66.7 million in Q2 2026.
- On a quarterly basis, Change in Account Payables fell 977.63% year-over-year to -$66.7 million in Q2 2026; TTM through Jun 2026 was -$28.1 million, a 125.95% decrease from a year earlier, with the FY2025 full-year figure at $36.8 million, down 25.66% from the prior year.
- Change in Account Payables was -$66.7 million for Q2 2026 at Vertex Pharmaceuticals, down from $35.6 million in the prior quarter.
- The five-year high for Change in Account Payables was $159.9 million in Q4 2022, with the low at -$69.9 million in Q3 2022.
- Average Change in Account Payables over 5 years is $12.5 million, with a median of $8.8 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables tumbled 3139.13% in 2022, then jumped 26100.0% in 2025.
- Over 5 years, Change in Account Payables stood at $159.9 million in 2022, then tumbled by 119.89% to -$31.8 million in 2023, then soared by 126.42% to $8.4 million in 2024, then surged by 355.95% to $38.3 million in 2025, then plunged by 274.15% to -$66.7 million in 2026.
- The last three Change in Account Payables figures came in at -$66.7 million (Q2 2026), $35.6 million (Q1 2026), and $38.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | -70.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 18.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | -66.70 Mn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | -29.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -66.70 Mn |
| Mar 31, 2026 | 35.60 Mn |
| Dec 31, 2025 | 38.30 Mn |
| Sep 30, 2025 | -35.30 Mn |
| Jun 30, 2025 | 7.60 Mn |
| Mar 31, 2025 | 26.20 Mn |
| Dec 31, 2024 | 8.40 Mn |
| Sep 30, 2024 | 66.10 Mn |
| Jun 30, 2024 | -25.10 Mn |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -31.80 Mn |
| Sep 30, 2023 | 9.20 Mn |
| Jun 30, 2023 | 35.60 Mn |
| Mar 31, 2023 | 35.70 Mn |
| Dec 31, 2022 | 159.90 Mn |
| Sep 30, 2022 | -69.90 Mn |
| Jun 30, 2022 | 45.30 Mn |
| Mar 31, 2022 | -14.50 Mn |
| Dec 31, 2021 | 53.90 Mn |
| Sep 30, 2021 | 2.30 Mn |
API Access
Vertex Pharmaceuticals Change in Account Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-account-payables", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();